ZEVRA THERAPEUTICS INC (ZVRA) Stock Earnings & Estimates
USA - NASDAQ:ZVRA - US4884452065 - Common Stock
7.67 USD
-0.27 (-3.4%)
7.89 USD
+0.22 (+2.87%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.46M -63.49% | 27.461M 162.53% | 23.612M -14.02% | 103.05M 336.43% | 158.96M 54.26% | 256.32M 61.25% | 343.73M 34.10% | 403.01M 17.25% | 474.73M 17.80% | 501.49M 5.64% | 511.92M 2.08% | |
| EBITDA YoY % growth | -23.91M -399.25% | -48.598M -103.25% | -80.614M -65.88% | -10.404M 87.09% | 7.854M 175.49% | 69.462M 784.42% | 158.81M 128.63% | 205.43M 29.36% | 499.19M 143.00% | 635.46M 27.30% | N/A | |
| EBIT YoY % growth | -24.85M -421.47% | -49.604M -99.61% | -87.003M -75.40% | -66.395M 23.69% | 51.608M 177.73% | 126.03M 144.21% | 202.48M 60.66% | 255.72M 26.29% | 320.63M 25.38% | 350.81M 9.41% | 383.32M 9.27% | |
| Operating Margin | -237.57% | -180.63% | -368.47% | -64.43% | 32.47% | 49.17% | 58.91% | 63.45% | 67.54% | 69.95% | 74.88% | |
| EPS YoY % growth | -0.69 -50.00% | -1.29 -86.96% | -2.26 -75.19% | 0.69 130.61% | 0.63 -9.15% | 1.84 193.02% | 3.21 74.45% | 3.93 22.38% | 4.09 4.09% | 4.33 5.73% | 4.85 11.96% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 94.83% | -0.02 96.49% | 0.06 206.25% | 0.11 -90.52% | 0.14 490.49% | 0.18 857.89% | 0.23 268.00% | 0.30 157.78% | 0.35 148.77% | 0.40 116.67% |
| Revenue Q2Q % growth | 27.175M 635.45% | 28.681M 138.15% | 35.182M 72.45% | 38.76M 49.76% | 42.175M 55.20% | 46.215M 61.13% | 50.082M 42.35% | 54.346M 40.21% | 58.15M 37.88% | 62.23M 34.65% |
| EBITDA Q2Q % growth | -612K 97.29% | 714K 107.91% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -468.007K 98.29% | 313.313K 102.03% | 6.887M 228.44% | 10.35M 183.95% | 14.604M 3,220.47% | 18.272M 5,731.86% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.21 352.08% | 1.53 | -0.32 | -20.80% |
| Q1 2025 Q2Q % growth | -0.06 85.00% | -0.19 | 0.13 | 68.49% |
| Q4 2024 Q2Q % growth | -0.69 -72.50% | -0.41 | -0.28 | -67.34% |
| Q3 2024 Q2Q % growth | -0.69 -72.50% | -0.43 | -0.26 | -60.59% |
| Q2 2024 Q2Q % growth | -0.48 -220.00% | -0.44 | -0.04 | -8.43% |
| Q1 2024 Q2Q % growth | -0.40 -17.65% | -0.49 | 0.09 | 17.96% |
| Q4 2023 Q2Q % growth | -0.40 -53.85% | -0.27 | -0.13 | -46.15% |
| Q3 2023 Q2Q % growth | -0.40 -110.53% | -0.30 | -0.10 | -31.82% |
| Q2 2023 Q2Q % growth | -0.15 21.05% | -0.35 | 0.20 | 57.17% |
| Q1 2023 Q2Q % growth | -0.34 -580.00% | -0.24 | -0.10 | -43.37% |
| Q4 2022 Q2Q % growth | -0.26 -225.00% | -0.18 | -0.08 | -47.06% |
| Q3 2022 Q2Q % growth | -0.19 -280.00% | -0.13 | -0.06 | -43.29% |
| Q2 2022 Q2Q % growth | -0.19 -190.48% | -0.12 | -0.07 | -55.23% |
| Q1 2022 Q2Q % growth | -0.05 90.74% | -0.06 | 0.01 | 10.87% |
| Q4 2021 Q2Q % growth | -0.08 92.52% | -0.08 | 0.00 | -4.58% |
| Q3 2021 Q2Q % growth | -0.05 92.19% | -0.08 | 0.03 | 34.64% |
| Q2 2021 Q2Q % growth | 0.21 31.25% | 0.23 | -0.02 | -8.50% |
| Q1 2021 Q2Q % growth | -0.54 69.32% | -0.17 | -0.37 | -211.42% |
| Q4 2020 Q2Q % growth | -1.07 -568.75% | -0.65 | -0.42 | -63.91% |
| Q3 2020 Q2Q % growth | -0.64 -166.67% | -0.82 | 0.18 | 21.57% |
| Q2 2020 Q2Q % growth | 0.16 103.03% | 0.00 | 0.16 | % |
| Q1 2020 Q2Q % growth | -1.76 76.09% | 0.16 | -1.92 | -1,178.43% |
| Q4 2019 Q2Q % growth | -0.16 | -1.39 | 1.23 | 88.47% |
| Q3 2019 Q2Q % growth | 0.96 | -3.05 | 4.01 | 131.51% |
| Q2 2019 Q2Q % growth | -5.28 | -6.94 | 1.66 | 23.88% |
| Q1 2019 Q2Q % growth | -7.36 | -7.51 | 0.15 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 25.881M 481.73% | 22.986M | 2.895M | 12.59% |
| Q1 2025 Q2Q % growth | 20.401M 495.65% | 17.297M | 3.104M | 17.95% |
| Q4 2024 Q2Q % growth | 12.043M -8.88% | 9.104M | 2.939M | 32.28% |
| Q3 2024 Q2Q % growth | 3.695M 27.63% | 4.966M | -1.271M | -25.59% |
| Q2 2024 Q2Q % growth | 4.449M -47.47% | 4.443M | 6K | 0.14% |
| Q1 2024 Q2Q % growth | 3.425M 18.96% | 3.839M | -414K | -10.78% |
| Q4 2023 Q2Q % growth | 13.217M 469.70% | 11.973M | 1.244M | 10.39% |
| Q3 2023 Q2Q % growth | 2.895M 0.87% | 3.447M | -552K | -16.01% |
| Q2 2023 Q2Q % growth | 8.47M 551.54% | 3.094M | 5.376M | 173.76% |
| Q1 2023 Q2Q % growth | 2.879M -27.48% | 2.708M | 171K | 6.31% |
| Q4 2022 Q2Q % growth | 2.32M -10.08% | 3.264M | -944K | -28.92% |
| Q3 2022 Q2Q % growth | 2.87M 45.69% | 3.264M | -394K | -12.07% |
| Q2 2022 Q2Q % growth | 1.3M -89.16% | 1.836M | -536K | -29.19% |
| Q1 2022 Q2Q % growth | 3.97M -67.24% | 3.126M | 844K | 27.00% |
| Q4 2021 Q2Q % growth | 2.58M 8.86% | 2.28M | 300K | 13.16% |
| Q3 2021 Q2Q % growth | 1.97M 2.07% | 2.228M | -258K | -11.58% |
| Q2 2021 Q2Q % growth | 11.99M 73.52% | 12.342M | -352K | -2.85% |
| Q1 2021 Q2Q % growth | 12.12M 479.90% | 2.142M | 9.978M | 465.83% |
| Q4 2020 Q2Q % growth | 2.37M 71.74% | 2.04M | 330K | 16.18% |
| Q3 2020 Q2Q % growth | 1.93M -83.16% | 1.938M | -8K | -0.41% |
| Q2 2020 Q2Q % growth | 6.91M | 6.885M | 25K | 0.36% |
| Q1 2020 Q2Q % growth | 2.09M | 5.916M | -3.826M | -64.67% |
| Q4 2019 Q2Q % growth | 1.38M | 5.66M | -4.28M | -75.62% |
| Q3 2019 Q2Q % growth | 11.46M | 2.992M | 8.468M | 283.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 46.87% | 70.83% | -27.57% | 2.58% |
| Revenue | 9.56% | 7.93% | 8.3% | 16.74% |